Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial-Reference-Cited by-同舟云学术

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

Published:2018-01 Issue:1 Volume:3 Page:25-36
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Newsome Philip Noel,Fox Richard,King Andrew L,Barton Darren,Than Nwe-Ni,Moore Joanna,Corbett Christopher,Townsend Sarah,Thomas James,Guo Kathy,Hull Diana,Beard Heather A,Thompson Jacqui,Atkinson Anne,Bienek Carol,McGowan Neil,Guha Neil,Campbell John,Hollyman Dan,Stocken Deborah,Yap Christina,Forbes Stuart John

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis;Williams;Lancet,2014

2. Trends in premature mortality in the USA by, race, and ethnicity from 1999 to 2014: an analysis of death certificate data;Shiels;Lancet,2017

3. Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension;Di Marco;Gastroenterology,2016

4. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration and function;Thomas;Hepatology,2011

5. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice;Sakaida;Hepatology,2004

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cell Therapy as a Potential Treatment of Non-Alcoholic Steatohepatitis-Related End-Stage Liver Disease: A Narrative Review;Current Stem Cell Reports;2024-07-02

2. Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing;Frontiers in Oncology;2024-06-10

3. Exploiting in silico modelling to enhance translation of liver cell therapies from bench to bedside;npj Regenerative Medicine;2024-05-09

4. A first-in-human clinical study of laparoscopic autologous myoblast sheet transplantation to prevent delayed perforation after duodenal endoscopic mucosal dissection;Stem Cell Research & Therapy;2024-04-23

5. Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers;Gut;2024-03-25